Todd Michael Pollack, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vietnam | 11 | 2022 | 408 | 1.030 |
Why?
|
Viral Load | 3 | 2019 | 3299 | 1.000 |
Why?
|
HIV Infections | 9 | 2022 | 16718 | 0.650 |
Why?
|
HIV Protease Inhibitors | 2 | 2009 | 430 | 0.550 |
Why?
|
HIV | 1 | 2019 | 1604 | 0.400 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1738 | 0.360 |
Why?
|
Dibenzothiazepines | 1 | 2009 | 103 | 0.340 |
Why?
|
Ritonavir | 1 | 2009 | 322 | 0.310 |
Why?
|
CD4 Lymphocyte Count | 3 | 2019 | 2559 | 0.280 |
Why?
|
Oligopeptides | 1 | 2009 | 1189 | 0.240 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 615 | 0.240 |
Why?
|
Anti-HIV Agents | 2 | 2019 | 4256 | 0.230 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.220 |
Why?
|
HIV-1 | 2 | 2018 | 6939 | 0.210 |
Why?
|
Capacity Building | 2 | 2015 | 248 | 0.210 |
Why?
|
Health Personnel | 5 | 2022 | 3218 | 0.190 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.180 |
Why?
|
Pyridines | 1 | 2009 | 2825 | 0.150 |
Why?
|
Health Facilities | 1 | 2022 | 573 | 0.150 |
Why?
|
Antipsychotic Agents | 1 | 2009 | 3057 | 0.140 |
Why?
|
Social Stigma | 1 | 2022 | 701 | 0.140 |
Why?
|
Infection Control | 2 | 2020 | 966 | 0.130 |
Why?
|
Patient Participation | 2 | 2020 | 1457 | 0.120 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 58 | 0.120 |
Why?
|
Public Sector | 1 | 2015 | 265 | 0.120 |
Why?
|
Education, Medical, Undergraduate | 1 | 2022 | 1008 | 0.110 |
Why?
|
Program Evaluation | 2 | 2020 | 2488 | 0.110 |
Why?
|
Education, Nursing, Continuing | 1 | 2013 | 75 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2020 | 2266 | 0.110 |
Why?
|
Anti-Retroviral Agents | 2 | 2019 | 1715 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5319 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2618 | 0.100 |
Why?
|
Cross Infection | 1 | 2020 | 1416 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2013 | 657 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2013 | 732 | 0.080 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 525 | 0.080 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2017 | 1873 | 0.080 |
Why?
|
Developing Countries | 1 | 2020 | 2815 | 0.080 |
Why?
|
Myocardial Infarction | 1 | 2007 | 11727 | 0.070 |
Why?
|
Drug Interactions | 1 | 2009 | 1460 | 0.060 |
Why?
|
Humans | 14 | 2022 | 744343 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25043 | 0.060 |
Why?
|
Adult | 5 | 2019 | 214055 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14722 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.050 |
Why?
|
Young Adult | 2 | 2018 | 56430 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
Male | 6 | 2020 | 350118 | 0.050 |
Why?
|
Quality Improvement | 1 | 2015 | 3749 | 0.050 |
Why?
|
Prospective Studies | 3 | 2020 | 53288 | 0.040 |
Why?
|
Female | 6 | 2020 | 380194 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6489 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15540 | 0.040 |
Why?
|
Middle Aged | 4 | 2018 | 213383 | 0.040 |
Why?
|
Ecosystem | 1 | 2020 | 474 | 0.030 |
Why?
|
Primary Health Care | 2 | 2022 | 4558 | 0.030 |
Why?
|
Medical Assistance | 1 | 2015 | 104 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9687 | 0.030 |
Why?
|
Aged | 2 | 2018 | 163280 | 0.030 |
Why?
|
Nuclear Family | 1 | 2015 | 318 | 0.030 |
Why?
|
Models, Nursing | 1 | 2013 | 44 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 911 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2020 | 12245 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 3923 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 1775 | 0.020 |
Why?
|
Models, Educational | 1 | 2013 | 377 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 18370 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 72290 | 0.020 |
Why?
|
Family | 1 | 2020 | 3147 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1316 | 0.020 |
Why?
|
Educational Measurement | 1 | 2013 | 1210 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
Vision Disorders | 1 | 2013 | 1058 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13408 | 0.020 |
Why?
|
Visual Acuity | 1 | 2013 | 2530 | 0.020 |
Why?
|
Nurses | 1 | 2013 | 2461 | 0.010 |
Why?
|
Child | 2 | 2020 | 77709 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8324 | 0.010 |
Why?
|
Curriculum | 1 | 2013 | 3605 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25625 | 0.010 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15076 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41006 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15226 | 0.010 |
Why?
|